Healthcare Sector

ABBV

Market Tracker

  • ABBV (Selected)

    AbbVie Inc.

ABBV Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ABBV Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ABBV Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ABBV Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/16/2026 CALL $190.00 1,246 +341 +37.68%
01/16/2026 PUT $190.00 1,397 +277 +24.73%
11/21/2025 CALL $210.00 1,661 +269 +19.32%
09/19/2025 CALL $190.00 1,062 +267 +33.58%
06/20/2025 CALL $197.50 915 +175 +23.65%
06/27/2025 CALL $197.50 208 +174 +511.76%
06/20/2025 PUT $195.00 3,238 -21 -0.64%
08/15/2025 PUT $170.00 2,331 -25 -1.06%
11/21/2025 CALL $200.00 1,417 -25 -1.73%
01/16/2026 CALL $210.00 5,403 -44 -0.81%
06/20/2025 CALL $190.00 3,980 -177 -4.26%
06/20/2025 CALL $200.00 8,481 -199 -2.29%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ABBV Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 53.76M 7.26B
Vanguard 500 Index Fund 2.32% 40.88M 5.52B
Fidelity 500 Index Fund 1.10% 19.39M 2.62B
SPDR S&P 500 ETF Trust 1.09% 19.15M 2.58B
American Mutual Fund Inc 1.00% 17.6M 2.38B
iShares Core S&P 500 ETF 0.89% 15.78M 2.13B
Vanguard Index-Value Index Fund 0.87% 15.28M 2.06B
Capital Income Builder, Inc. 0.84% 14.87M 2.01B
Select Sector SPDR Fund-Health Care 0.81% 14.36M 1.94B
Washington Mutual Investors Fund 0.75% 13.22M 1.78B

ABBV News

  • Giant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight

    06/12 01:00 pm

    GlobeNewswire Inc.

    Read more
  • FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)

    06/11 05:07 pm

    Benzinga

    Read more
  • Rheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies

    06/10 04:53 am

    GlobeNewswire Inc.

    Read more
  • CEREVEL ALERT: Bragar Eagel & Squire, P.C. is Investigating Cerevel Therapeutics Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    06/04 09:00 pm

    GlobeNewswire Inc.

    Read more
  • Contact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Cerevel Therapeutics Holdings, Inc. (ABBV)

    06/04 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Meta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades'

    06/02 08:21 am

    Benzinga

    Read more
  • Drug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities

    05/29 05:42 am

    GlobeNewswire Inc.

    Read more
  • CERE DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE

    05/28 03:27 pm

    GlobeNewswire Inc.

    Read more
  • AbbVie To Present Cancer Trial Data At Upcoming ASCO Event

    05/27 11:21 am

    Benzinga

    Read more
  • Prurigo Nodularis Market - Global and Regional Analysis and Forecasts 2025-2035 | Advancements in Biologic Therapies Revolutionize Prurigo Nodularis Treatment

    05/26 10:53 am

    GlobeNewswire Inc.

    Read more
  • CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE

    05/25 06:32 pm

    GlobeNewswire Inc.

    Read more
  • U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

    05/24 04:11 am

    The Motley Fool

    Read more
  • Cerevel Therapeutics Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 3, 2025 Deadline to file Lead Plaintiff Motion

    05/19 05:59 pm

    GlobeNewswire Inc.

    Read more
  • Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.

    05/18 12:05 pm

    The Motley Fool

    Read more
  • Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

    05/12 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Contract Research and Manufacturing Services (CRAMS) Business Report 2025: Market to Reach $211.4 Billion by 2030, Fueled by Growing Demand for Biologics and Biosimilars

    05/08 10:55 am

    GlobeNewswire Inc.

    Read more
  • Generic Oncology Drugs Market Size Estimated to Reach USD 30,998 Mn by 2034, Rising Global Cancer Cases Increase Demand for Affordable Treatments

    05/07 11:00 am

    GlobeNewswire Inc.

    Read more
  • Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – ABBV

    05/05 01:53 pm

    GlobeNewswire Inc.

    Read more
  • Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

    05/04 04:49 am

    The Motley Fool

    Read more
  • Invest in These ETFs to Prepare Your Portfolio for a Recession

    05/03 08:37 am

    The Motley Fool

    Read more
  • 3 Dividend Stocks to Buy and Hold for the Next Decade

    04/28 07:47 am

    The Motley Fool

    Read more
  • Should Investors Be Worried About Dividend King AbbVie?

    04/28 04:42 am

    The Motley Fool

    Read more
  • 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

    04/26 06:05 pm

    The Motley Fool

    Read more
  • Why AbbVie Stock Topped the Market Today

    04/25 05:17 pm

    The Motley Fool

    Read more
  • Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

    04/22 05:37 pm

    The Motley Fool

    Read more
  • Is AbbVie Stock a Buy?

    04/20 08:15 am

    The Motley Fool

    Read more
  • ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

    04/18 05:12 pm

    GlobeNewswire Inc.

    Read more
  • Atopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market

    04/18 04:26 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

    04/14 05:33 pm

    GlobeNewswire Inc.

    Read more
  • Male Hypogonadism Market Forecast Report and Company Analysis 2025-2034 Featuring AbbVie, Bayer, Eli Lilly, Endo, Ferring, Perrigo, Pfizer, Sanofi, Teva, and Viatris

    04/10 10:00 am

    GlobeNewswire Inc.

    Read more
  • Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

    04/10 05:59 am

    GlobeNewswire Inc.

    Read more
  • 2 Top Dividend Stocks That Could Set You Up for Life

    04/09 07:00 am

    The Motley Fool

    Read more
  • Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.

    04/09 05:44 am

    The Motley Fool

    Read more
  • Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities

    04/08 04:52 am

    GlobeNewswire Inc.

    Read more
  • Global Cosmeceuticals Market Size to Reach USD 182.17 Bn by 2032, at a CAGR of 9.6%, says Coherent Market Insights

    04/08 12:50 am

    GlobeNewswire Inc.

    Read more
  • 3 Dividend Stocks to Buy and Hold for the Next Decade

    04/06 06:44 am

    The Motley Fool

    Read more
  • 2 Dividend Stocks to Buy Hand Over Fist in April

    04/05 08:30 am

    The Motley Fool

    Read more
  • Trump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More

    04/03 12:30 pm

    Benzinga

    Read more
  • Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

    03/31 04:53 am

    The Motley Fool

    Read more
  • Global Autoimmune Disease Therapeutics Market to reach USD 226,194.0 Million by 2035 Amid Rising Prevalence and Advancements in Biologic Therapies | Future Market Insights, Inc.

    03/23 08:30 pm

    GlobeNewswire Inc.

    Read more
  • Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.

    03/21 11:29 pm

    GlobeNewswire Inc.

    Read more
  • Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends

    03/20 09:31 am

    The Motley Fool

    Read more
  • AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients

    03/17 02:02 pm

    Benzinga

    Read more
  • 5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond

    03/17 07:45 am

    The Motley Fool

    Read more
  • 1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction

    03/16 06:19 pm

    The Motley Fool

    Read more
  • 3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

    03/14 05:51 am

    The Motley Fool

    Read more
  • Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030

    03/12 11:50 am

    GlobeNewswire Inc.

    Read more
  • Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results

    03/11 07:30 am

    GlobeNewswire Inc.

    Read more
  • Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas

    03/10 04:53 pm

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: